MPU
MDXH icon

MVM Partners (UK)’s MDxHealth MDXH Stock Holding History

MVM Partners (UK)’s Portfolio MDXH Stock Details MDXH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-916,666
Closed -$7.56M – 2
2022
Q2 		$7.56M Hold
916,666
– – 2.67% 3
2022
Q1 		$7.23M Hold
916,666
– – 2.58% 3
2021
Q4 		$8.6M Buy
+916,666
New +$8.98M 3.07% 3

Other funds holding MDXH

BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

MVM Partners (UK)'s MDXH Position: Q3 2022 in Review

MVM Partners (UK) sold out of MDxHealth (MDXH) in Q3 2022, closing a stake of 916,666 shares — an estimated $7.56M sold.

MVM Partners (UK) first reported a position in MDXH in Q4 2021 and held it in 3 quarters. The position peaked at $8.6M in Q4 2021. 4 funds tracked by Wall St. Rank hold MDXH as of Q3 2022.

  • MVM Partners (UK) reported no remaining MDxHealth position as of Q3 2022 after selling out during the quarter.
  • MVM Partners (UK) sold 916,666 MDxHealth shares in Q3 2022, an estimated $7.56M.
  • MVM Partners (UK) first reported a position in MDxHealth in Q4 2021 and held it in 3 quarters.
  • MVM Partners (UK)'s MDxHealth position peaked at $8.6M in Q4 2021.
  • 4 funds tracked by Wall St. Rank held MDxHealth as of Q3 2022.

Based on MVM Partners (UK)'s 13F filing for Q3 2022, filed 25 Oct 2024.